Remed

(주)리메드 · KOSDAQ · 302550 · Industry: Manufacture of other medical and surgical equipment and orthopedic appliances n.e.c.

Key metrics

Earnings

Revenue, Q3 2026₩7.7bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ+4.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+31.9% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026₩1.6bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+71.7% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY+495.6% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩2.0bn As of Oct 19, 2026 Source 1 ↗
Treasury shares cancelled (number), last 3 months701,519 shares As of Oct 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months, % of shares2.3% As of Oct 19, 2026 Source 1 ↗, Source 2 ↗
Buyback decided, last 12 months₩5.0bn As of Aug 4, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Buyback decided, last 12 months, % of sharesNot available
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩6.0bn As of Oct 19, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Treasury shares cancelled (number), last 12 months1,922,034 shares As of Oct 19, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Treasury shares cancelled, last 12 months, % of shares6.3% As of Oct 19, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩10.0bn As of Oct 14, 2026 Source 1
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months3,604,902 shares As of Oct 14, 2026 Source 1
Potential new shares, % of shares11.9% As of Oct 14, 2026 Source 1, Source 2 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months19 As of Nov 19, 2026
DART filings, previous 3 months11 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)12,000 shares As of Apr 9, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗
Open-market buys, last 12 months (amount)₩35m As of Apr 9, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)12,000 shares As of Apr 9, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗
Insiders who bought, last 12 months4 As of Apr 9, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗

Insider transactions (last 12 months)

Open-market buys: 12,000 shares (₩35m). Open-market sells: 0 shares (₩0). Net open-market buying: +12,000 shares. Insiders who bought: 4.

Trade dateInsider (role)TypeSharesPriceAmount
Nov 13, 2026I Geun Yong (Registered director, Controlling shareholder)Other (OTC sell)-1,802,451 shares₩2,774₩5.0bn
Apr 9, 2026Kim Tae-gun (Registered director)Open-market buy+3,300 shares₩2,880₩10m
Feb 25, 2026Shin Dae-hyeon (Registered director)Open-market buy+2,500 shares₩3,170₩8m
Feb 5, 2026Song Jong-eun (Registered director)Open-market buy+1,000 shares₩2,760₩3m
Feb 5, 2026Song Jong-eun (Registered director)Open-market buy+300 shares₩2,770₩831,000
Feb 3, 2026Song Jong-eun (Registered director)Open-market buy+600 shares₩2,855₩2m
Feb 2, 2026Song Jong-eun (Registered director)Open-market buy+600 shares₩2,880₩2m
Jan 30, 2026Song Jong-eun (Registered director)Open-market buy+600 shares₩2,935₩2m
Jan 28, 2026Shin Dae-hyeon (Registered director)Open-market buy+100 shares₩2,785₩278,500
Jan 27, 2026Lee Jeong-su (Registered director)Open-market buy+45 shares₩2,755₩123,975
Jan 27, 2026Lee Jeong-su (Registered director)Open-market buy+2,955 shares₩2,760₩8m

Annual financials

YearRevenueOperating income
2025₩24.5bn₩726m
2024₩25.6bn₩1.1bn
2023₩18.5bn-₩2.9bn

Filing timeline